Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Pursglove Geordan Garrett received 350,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Pursglove Geordan Garrett (Director, CEO and Chairman of the Board) received 350,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 350,000 shares. Filed Apr 17, 2026 (Form 4).
- Awarded
- 350,000 shares
- Holding after
- 350,000 shares
- Trading plan
- No
- Role
- Director, CEO and Chairman of the Board
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Award | 350,000 | 350,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Pursglove Geordan Garrett
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026